Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesDigital X-RayCan eye gaze data from radiologists make AI more human?Researcher Jeremy Wolfe, MD, discusses an emerging trend of integrating eye gaze data from radiologists into AI algorithms.PodcastsPodcast: Bryan discusses surviving radiology cuts, 2-year lockdown, and categorical changePractice ManagementMICI Q3: Radiology administrators mixed on the state of medical imagingMolecular ImagingBrain PET tracer delivered intranasally for first time in humansSponsor ContentWhen CT meets the power of AI everyone benefits.
